We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $214M
1-Year Est. Return 62.74%
This Fund
S&P 500
This Quarter Est. Return
-5.27%
1 Year Est. Return
+62.74%
3 Year Est. Return
+258.24%
5 Year Est. Return
+582.22%
10 Year Est. Return
+8,737.07%
AUM
$182M
AUM Growth
-$18.6M
Cap. Flow
+$4.63M
Cap. Flow %
2.55%
Top 10 Hldgs %
89.05%
Holding
42
New
2
Increased
2
Reduced
2
Closed
4

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$5.09M
2
ALDX icon
Aldeyra Therapeutics
ALDX
+$1.45M
3
OSK icon
Oshkosh
OSK
+$923K
4
AG icon
First Majestic Silver
AG
+$398K

Top Sells

Rank Stock Value
1
VMW
VMware, Inc
VMW
+$1.03M
2
XCUR icon
Exicure
XCUR
+$962K
3
ABEO icon
Abeona Therapeutics
ABEO
+$473K
4
SNGX icon
Soligenix
SNGX
+$316K
5
SVM
Silvercorp Metals
SVM
+$267K

Sector Composition

Rank Sector Weight
1 Healthcare 85.51%
2 Miscellaneous 4.09%
3 Technology 3.12%
4 Materials 2.61%
5 Financials 2.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$124M 67.92%
896,844
+40,000
+5% +$5.09M
APLT
2
DELISTED
Applied Therapeutics
APLT
$9.24M 5.08%
1,032,123
– –
ENTX icon
3
Entera Bio
ENTX
$488M
$6.99M 3.84%
2,484,275
– –
EIGR
4
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.6M 1.98%
23,141
– –
CRBP icon
5
Corbus Pharmaceuticals
CRBP
$156M
$3.11M 1.71%
168,196
– –
BX icon
6
Blackstone
BX
$96.3B
$3.1M 1.71%
24,000
– –
ALDX icon
7
Aldeyra Therapeutics
ALDX
$88.1M
$3.04M 1.67%
759,405
+190,000
+33% +$1.45M
ANET icon
8
Arista Networks
ANET
$237B
$1.93M 1.06%
55,200
– –
AMD icon
9
Advanced Micro Devices
AMD
$805B
$1.78M 0.98%
12,350
– –
CVS icon
10
CVS Health
CVS
$122B
$1.46M 0.8%
14,500
– –
TMO icon
11
Thermo Fisher Scientific
TMO
$227B
$1.4M 0.77%
2,100
– –
LUMN icon
12
Lumen
LUMN
$7.25B
$1.25M 0.69%
100,000
– –
ALT icon
13
Altimmune
ALT
$642M
$1.22M 0.67%
132,978
– –
BAH icon
14
Booz Allen Hamilton
BAH
$9.52B
$1.07M 0.59%
13,000
– –
MO icon
15
Altria Group
MO
$118B
$1.06M 0.58%
22,700
– –
V icon
16
Visa
V
$701B
$1.05M 0.58%
4,850
– –
ASML icon
17
ASML
ASML
$605B
$1.01M 0.56%
1,280
– –
GLW icon
18
Corning
GLW
$124B
$968K 0.53%
26,600
– –
OSK icon
19
Oshkosh
OSK
$9B
$925K 0.51%
+8,450
New +$923K
ABEO icon
20
Abeona Therapeutics
ABEO
$311M
$651K 0.36%
88,630
-25,761
-23% -$473K
OR icon
21
OR Royalties Inc
OR
$6.75B
$579K 0.32%
190,000
– –
SA
22
Seabridge Gold
SA
$3.19B
$528K 0.29%
32,000
– –
FNV icon
23
Franco-Nevada
FNV
$51.3B
$519K 0.29%
3,750
– –
MMX
24
DELISTED
Maverix Metals Inc. Common Shares
MMX
$501K 0.28%
115,000
– –
KL
25
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$451K 0.25%
10,750
– –
1
2

Similar funds

PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return
BCA
Bayshore Capital Advisors Tampa, Florida $214M AUM
KA
Kearns & Associates Palos Verdes Estates, California $214M AUM 23.8% 1-Year Est. Return
VCS
Vaughan & Co Securities Ridgewood, New Jersey $214M AUM 27.87% 1-Year Est. Return
PIMC
Praesidium Investment Management Company New York $214M AUM 1.94% 1-Year Est. Return
HIW
Holos Integrated Wealth Kennett Square, Pennsylvania $214M AUM 14.99% 1-Year Est. Return
FVIM
Fort Vancouver Investment Management Vancouver, Washington $214M AUM 21.54% 1-Year Est. Return
SCGM
Starwood Capital Group Management Miami Beach, Florida $214M AUM 4.55% 1-Year Est. Return

Knoll Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Knoll Capital Management held 42 positions worth $182M, down 9.3% from $201M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Knoll Capital Management's Q4 2021 filing shows 2 new, 2 increased, 2 reduced and 4 closed positions. Its largest new stake was Oshkosh: 8,450 shares worth $925K. The largest sale was VMware, Inc, an estimated $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 87% a quarter earlier, followed by Miscellaneous and Technology.

  • Knoll Capital Management's largest Q4 2021 buy was Oshkosh: 8,450 shares worth $925K.
  • Knoll Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q4 2021, an estimated $5.09M increase.
  • Knoll Capital Management's biggest Q4 2021 reduction was Abeona Therapeutics, cutting an estimated $473K.
  • Knoll Capital Management fully exited VMware, Inc in Q4 2021, selling an estimated $1.03M.
  • Knoll Capital Management's ten largest holdings make up 89% of its $182M portfolio in Q4 2021.
  • Knoll Capital Management opened 2 new positions and closed 4 in Q4 2021.
  • Knoll Capital Management's portfolio value fell 9.3% quarter-over-quarter to $182M.

Based on Knoll Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.